Structure

Physi-Chem Properties

Molecular Weight:  538.09
Volume:  521.816
LogP:  6.077
LogD:  2.301
LogS:  -4.004
# Rotatable Bonds:  3
TPSA:  181.8
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.177
Synthetic Accessibility Score:  3.034
Fsp3:  0.0
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.259
MDCK Permeability:  8.156965122907422e-06
Pgp-inhibitor:  0.021
Pgp-substrate:  0.02
Human Intestinal Absorption (HIA):  0.565
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  98.79447937011719%
Volume Distribution (VD):  0.463
Pgp-substrate:  4.027957439422607%

ADMET: Metabolism

CYP1A2-inhibitor:  0.895
CYP1A2-substrate:  0.101
CYP2C19-inhibitor:  0.642
CYP2C19-substrate:  0.034
CYP2C9-inhibitor:  0.554
CYP2C9-substrate:  0.879
CYP2D6-inhibitor:  0.161
CYP2D6-substrate:  0.462
CYP3A4-inhibitor:  0.236
CYP3A4-substrate:  0.057

ADMET: Excretion

Clearance (CL):  2.862
Half-life (T1/2):  0.521

ADMET: Toxicity

hERG Blockers:  0.164
Human Hepatotoxicity (H-HT):  0.078
Drug-inuced Liver Injury (DILI):  0.984
AMES Toxicity:  0.191
Rat Oral Acute Toxicity:  0.031
Maximum Recommended Daily Dose:  0.83
Skin Sensitization:  0.922
Carcinogencity:  0.037
Eye Corrosion:  0.003
Eye Irritation:  0.908
Respiratory Toxicity:  0.035

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC111112

Natural Product ID:  NPC111112
Common Name*:   Robustaflavone
IUPAC Name:   6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
Synonyms:   Robustaflavone
Standard InCHIKey:  BORWSEZUWHQTOK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C30H18O10/c31-15-4-1-13(2-5-15)23-11-22(37)29-26(39-23)12-20(35)27(30(29)38)17-7-14(3-6-18(17)33)24-10-21(36)28-19(34)8-16(32)9-25(28)40-24/h1-12,31-35,38H
SMILES:  Oc1ccc(cc1)c1cc(=O)c2c(o1)cc(c(c2O)c1cc(ccc1O)c1cc(=O)c2c(o1)cc(cc2O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL63677
PubChem CID:   5281694
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001586] Biflavonoids and polyflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2508 Selaginella delicatula Species Selaginellaceae Eukaryota n.a. n.a. n.a. PMID[10843573]
NPO33250 rhus succedanea Species Anacardiaceae Eukaryota sap n.a. n.a. PMID[12444713]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. PMID[20335035]
NPO29798 Podocarpus imbricatus Species Podocarpaceae Eukaryota twigs and leaves n.a. n.a. PMID[24953598]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. PMID[25559759]
NPO7175 Eucalyptus robusta Species Myrtaceae Eukaryota n.a. n.a. n.a. PMID[27142786]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. PMID[29144743]
NPO40105 Dietes bicolor Species Iridaceae Eukaryota n.a. n.a. n.a. PMID[29381070]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. PMID[31244143]
NPO9740 Dacrycarpus imbricatus Species Podocarpaceae Eukaryota Twigs n.a. n.a. PMID[32786878]
NPO33250 rhus succedanea Species Anacardiaceae Eukaryota seed kernels Fukuoka, Japan n.a. PMID[9322359]
NPO30600 Araucaria sp Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30767 Juniperus sp Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7175 Eucalyptus robusta Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29798 Podocarpus imbricatus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30918 Rhus sp Species Anacardiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO4099 Araucaria sp. Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20980 Juniperus sp. Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7175 Eucalyptus robusta Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3580 Rana amurensis Species Ranidae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28902 Rhus sp. Species Anacardiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3469 Pteris dactylina Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9740 Dacrycarpus imbricatus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3580 Rana amurensis Species Ranidae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7175 Eucalyptus robusta Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO2508 Selaginella delicatula Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14158 Selaginella tamariscina Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3469 Pteris dactylina Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1744 Discaria serratifolia Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9180 Pyrostegia venusta Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12510 Aronia arbutifolia Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9740 Dacrycarpus imbricatus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO998 Justicia hayatai Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3580 Rana amurensis Species Ranidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13070 Clibadium mexiae Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7175 Eucalyptus robusta Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13016 Viscaria viscosa Species Caryophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28400 Selaginella pulvinata Species Selaginellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11636 Ideopsis similis Species Nymphalidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens EC50 = 250.0 nM PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens EC90 = 2.2 uM PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 337000.0 nM PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 1.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 5.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 93.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 106.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 97.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 86.0 n.a. PMID[489819]
NPT65 Cell Line HepG2 Homo sapiens Relative level = 138.0 n.a. PMID[489819]
NPT80 Cell Line Raji Homo sapiens IC50 > 100000.0 nM PMID[489821]
NPT1307 Cell Line Calu-1 Homo sapiens IC50 > 100000.0 nM PMID[489821]
NPT111 Cell Line K562 Homo sapiens IC50 > 100000.0 nM PMID[489821]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 > 100000.0 nM PMID[489821]
NPT1306 Cell Line WISH Homo sapiens IC50 > 100000.0 nM PMID[489821]
NPT165 Cell Line HeLa Homo sapiens IC50 > 100000.0 nM PMID[489821]
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 IC50 = 65000.0 nM PMID[489822]
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 Inhibition = 91.4 % PMID[489822]
NPT927 Cell Line PBMC Homo sapiens IC50 = 77000.0 nM PMID[489822]
NPT4285 Individual Protein Photosystem I iron-sulfur center Spinacia oleracea Activity = 100.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 9.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 35.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 89.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 50.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 100.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 29.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 43.0 % PMID[489824]
NPT4284 Individual Protein Photosystem Q(B) protein Spinacia oleracea Activity = 57.0 % PMID[489824]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 6200.0 nM PMID[489825]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Ki = 6800.0 nM PMID[489825]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 5.3 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 6.0 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 2.7 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 45.3 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 4.0 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 3.0 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 2.3 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Activity = 92.3 % PMID[489827]
NPT521 Cell Line RBL-2H3 Rattus norvegicus Inhibition = 49.0 % PMID[489827]
NPT2740 Cell Line Neutrophils IC50 = 1010.0 nM PMID[489827]
NPT2740 Cell Line Neutrophils Inhibition = 105.1 % PMID[489827]
NPT2740 Cell Line Neutrophils IC50 = 450.0 nM PMID[489827]
NPT2740 Cell Line Neutrophils Inhibition = 103.2 % PMID[489827]
NPT279 Individual Protein Leukocyte elastase Homo sapiens IC50 = 1330.0 nM PMID[489827]
NPT3140 Cell Line MGC-803 Homo sapiens IC50 = 15570.0 nM PMID[489828]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 19150.0 nM PMID[489828]
NPT81 Cell Line A549 Homo sapiens IC50 = 21380.0 nM PMID[489828]
NPT550 Cell Line T-24 Homo sapiens IC50 = 21090.0 nM PMID[489828]
NPT568 Individual Protein Matrix metalloproteinase-2 Homo sapiens IC50 = 10220.0 nM PMID[489828]
NPT280 Individual Protein Matrix metalloproteinase 9 Homo sapiens IC50 = 11850.0 nM PMID[489828]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis Inhibition = 0.0 % PMID[489818]
NPT2 Others Unspecified Ratio = 153.0 n.a. PMID[489819]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 > 100000.0 nM PMID[489822]
NPT2 Others Unspecified Selectivity Index < 1.0 n.a. PMID[489822]
NPT740 Individual Protein Beta-secretase 1 Homo sapiens IC50 > 10000.0 nM PMID[489823]
NPT597 Organism Spinacia oleracea Spinacia oleracea Inhibition = 22.0 % PMID[489824]
NPT597 Organism Spinacia oleracea Spinacia oleracea IC50 = 88000.0 nM PMID[489824]
NPT2 Others Unspecified Activity = 76.0 % PMID[489824]
NPT597 Organism Spinacia oleracea Spinacia oleracea IC50 = 44000.0 nM PMID[489824]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 250.0 nM PMID[489826]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC111112 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC222713
1.0 High Similarity NPC138299
1.0 High Similarity NPC67322
0.9863 High Similarity NPC194593
0.9863 High Similarity NPC290830
0.9863 High Similarity NPC72425
0.9863 High Similarity NPC71061
0.9863 High Similarity NPC303485
0.9796 High Similarity NPC159707
0.9796 High Similarity NPC265624
0.9796 High Similarity NPC215203
0.9796 High Similarity NPC52611
0.9796 High Similarity NPC121649
0.9796 High Similarity NPC248739
0.9796 High Similarity NPC205026
0.9796 High Similarity NPC100049
0.9796 High Similarity NPC150908
0.9796 High Similarity NPC14606
0.9796 High Similarity NPC158027
0.9796 High Similarity NPC186227
0.9724 High Similarity NPC288840
0.9724 High Similarity NPC291746
0.9662 High Similarity NPC254351
0.9662 High Similarity NPC182555
0.9662 High Similarity NPC66441
0.953 High Similarity NPC300668
0.953 High Similarity NPC134171
0.947 High Similarity NPC177650
0.947 High Similarity NPC55443
0.947 High Similarity NPC18699
0.9467 High Similarity NPC32867
0.9408 High Similarity NPC186325
0.9408 High Similarity NPC312993
0.9396 High Similarity NPC174086
0.9375 High Similarity NPC14871
0.9346 High Similarity NPC273467
0.9346 High Similarity NPC189552
0.9342 High Similarity NPC51760
0.9342 High Similarity NPC295090
0.9338 High Similarity NPC54830
0.9338 High Similarity NPC56049
0.9338 High Similarity NPC69531
0.929 High Similarity NPC259757
0.9281 High Similarity NPC121647
0.9276 High Similarity NPC475184
0.9257 High Similarity NPC122894
0.9205 High Similarity NPC121568
0.9205 High Similarity NPC324447
0.9195 High Similarity NPC3642
0.9189 High Similarity NPC166757
0.9189 High Similarity NPC14001
0.9184 High Similarity NPC278175
0.9184 High Similarity NPC257236
0.9178 High Similarity NPC78803
0.9178 High Similarity NPC214236
0.9178 High Similarity NPC59739
0.9178 High Similarity NPC293852
0.9178 High Similarity NPC217083
0.9178 High Similarity NPC299080
0.9178 High Similarity NPC62840
0.9167 High Similarity NPC469664
0.915 High Similarity NPC1796
0.915 High Similarity NPC257166
0.9145 High Similarity NPC258474
0.9145 High Similarity NPC201227
0.9139 High Similarity NPC78324
0.9139 High Similarity NPC115601
0.9139 High Similarity NPC39154
0.9139 High Similarity NPC208011
0.9128 High Similarity NPC244407
0.9122 High Similarity NPC220418
0.9116 High Similarity NPC11700
0.9116 High Similarity NPC24821
0.9116 High Similarity NPC9117
0.9116 High Similarity NPC219915
0.9116 High Similarity NPC293053
0.9116 High Similarity NPC212932
0.9116 High Similarity NPC190637
0.911 High Similarity NPC26238
0.9103 High Similarity NPC38591
0.9103 High Similarity NPC301217
0.9103 High Similarity NPC303633
0.9103 High Similarity NPC96565
0.9103 High Similarity NPC216978
0.9103 High Similarity NPC220062
0.9103 High Similarity NPC55018
0.9097 High Similarity NPC301256
0.9097 High Similarity NPC312273
0.9091 High Similarity NPC105584
0.9091 High Similarity NPC15815
0.9091 High Similarity NPC51247
0.9091 High Similarity NPC123544
0.9085 High Similarity NPC198489
0.9085 High Similarity NPC309648
0.9085 High Similarity NPC61112
0.9085 High Similarity NPC192587
0.9067 High Similarity NPC5173
0.906 High Similarity NPC201731
0.906 High Similarity NPC24673
0.906 High Similarity NPC475348
0.906 High Similarity NPC97716
0.906 High Similarity NPC237635
0.906 High Similarity NPC261271
0.906 High Similarity NPC104406
0.906 High Similarity NPC79469
0.9054 High Similarity NPC319752
0.9054 High Similarity NPC470135
0.9054 High Similarity NPC273538
0.9054 High Similarity NPC39045
0.9054 High Similarity NPC216538
0.9054 High Similarity NPC326500
0.9054 High Similarity NPC282957
0.9054 High Similarity NPC194949
0.9054 High Similarity NPC470136
0.9048 High Similarity NPC200694
0.9048 High Similarity NPC473042
0.9041 High Similarity NPC159275
0.9041 High Similarity NPC172986
0.9041 High Similarity NPC241100
0.9041 High Similarity NPC270883
0.9041 High Similarity NPC261227
0.9038 High Similarity NPC473011
0.9038 High Similarity NPC473012
0.9034 High Similarity NPC201395
0.9032 High Similarity NPC292863
0.9032 High Similarity NPC184326
0.9032 High Similarity NPC42965
0.9032 High Similarity NPC226462
0.9032 High Similarity NPC98023
0.9032 High Similarity NPC195136
0.9026 High Similarity NPC324358
0.9026 High Similarity NPC183
0.9026 High Similarity NPC318527
0.9026 High Similarity NPC322459
0.9026 High Similarity NPC323627
0.9026 High Similarity NPC287789
0.9026 High Similarity NPC112954
0.9026 High Similarity NPC271741
0.902 High Similarity NPC79375
0.902 High Similarity NPC37253
0.9007 High Similarity NPC29777
0.9007 High Similarity NPC471115
0.9007 High Similarity NPC151973
0.9 High Similarity NPC321623
0.9 High Similarity NPC6511
0.9 High Similarity NPC266572
0.9 High Similarity NPC152233
0.9 High Similarity NPC161191
0.9 High Similarity NPC296869
0.9 High Similarity NPC189087
0.8993 High Similarity NPC470133
0.8993 High Similarity NPC470132
0.8993 High Similarity NPC109183
0.8993 High Similarity NPC476088
0.8993 High Similarity NPC474161
0.8993 High Similarity NPC470131
0.8993 High Similarity NPC470134
0.8993 High Similarity NPC306488
0.8993 High Similarity NPC178343
0.8993 High Similarity NPC5820
0.8993 High Similarity NPC124729
0.8993 High Similarity NPC228779
0.8993 High Similarity NPC473078
0.8987 High Similarity NPC171985
0.8987 High Similarity NPC320741
0.8986 High Similarity NPC38219
0.8981 High Similarity NPC63438
0.8981 High Similarity NPC473009
0.898 High Similarity NPC147688
0.898 High Similarity NPC156590
0.898 High Similarity NPC118840
0.898 High Similarity NPC205006
0.898 High Similarity NPC64908
0.898 High Similarity NPC282300
0.898 High Similarity NPC110969
0.8974 High Similarity NPC18380
0.8974 High Similarity NPC137232
0.8973 High Similarity NPC78913
0.8973 High Similarity NPC18260
0.8973 High Similarity NPC217186
0.8973 High Similarity NPC53181
0.8968 High Similarity NPC90497
0.8968 High Similarity NPC195167
0.8961 High Similarity NPC137100
0.8954 High Similarity NPC329844
0.8954 High Similarity NPC326592
0.8954 High Similarity NPC109594
0.8954 High Similarity NPC112701
0.8947 High Similarity NPC204561
0.8947 High Similarity NPC316960
0.8947 High Similarity NPC317715
0.8947 High Similarity NPC209846
0.8947 High Similarity NPC309512
0.8947 High Similarity NPC148945
0.8947 High Similarity NPC289774
0.8947 High Similarity NPC178484
0.8947 High Similarity NPC78835
0.8947 High Similarity NPC477897
0.8947 High Similarity NPC328740
0.894 High Similarity NPC221868

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC111112 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9184 High Similarity NPD7410 Clinical (unspecified phase)
0.9054 High Similarity NPD4378 Clinical (unspecified phase)
0.8974 High Similarity NPD6959 Discontinued
0.8924 High Similarity NPD7852 Clinical (unspecified phase)
0.8896 High Similarity NPD8443 Clinical (unspecified phase)
0.8758 High Similarity NPD4380 Phase 2
0.8718 High Similarity NPD7768 Phase 2
0.8701 High Similarity NPD7411 Suspended
0.8581 High Similarity NPD1550 Clinical (unspecified phase)
0.8581 High Similarity NPD1552 Clinical (unspecified phase)
0.8571 High Similarity NPD1510 Phase 2
0.8544 High Similarity NPD3749 Approved
0.8523 High Similarity NPD1549 Phase 2
0.8487 Intermediate Similarity NPD7390 Discontinued
0.8487 Intermediate Similarity NPD1511 Approved
0.8471 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8428 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8411 Intermediate Similarity NPD3750 Approved
0.8389 Intermediate Similarity NPD2796 Approved
0.8377 Intermediate Similarity NPD1512 Approved
0.8354 Intermediate Similarity NPD7819 Suspended
0.8344 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6166 Phase 2
0.8313 Intermediate Similarity NPD7075 Discontinued
0.8303 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8299 Intermediate Similarity NPD1240 Approved
0.8239 Intermediate Similarity NPD2801 Approved
0.8224 Intermediate Similarity NPD2800 Approved
0.8221 Intermediate Similarity NPD6232 Discontinued
0.8188 Intermediate Similarity NPD1607 Approved
0.8182 Intermediate Similarity NPD7473 Discontinued
0.8176 Intermediate Similarity NPD1934 Approved
0.8176 Intermediate Similarity NPD6801 Discontinued
0.8125 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8105 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD3748 Approved
0.8025 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1243 Approved
0.7976 Intermediate Similarity NPD7054 Approved
0.7975 Intermediate Similarity NPD5403 Approved
0.7974 Intermediate Similarity NPD2344 Approved
0.7963 Intermediate Similarity NPD3817 Phase 2
0.7929 Intermediate Similarity NPD7472 Approved
0.7929 Intermediate Similarity NPD7074 Phase 3
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD2313 Discontinued
0.7917 Intermediate Similarity NPD3818 Discontinued
0.7898 Intermediate Similarity NPD6799 Approved
0.7882 Intermediate Similarity NPD6797 Phase 2
0.7882 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD5494 Approved
0.7875 Intermediate Similarity NPD3226 Approved
0.787 Intermediate Similarity NPD5844 Phase 1
0.7862 Intermediate Similarity NPD920 Approved
0.7853 Intermediate Similarity NPD5402 Approved
0.7848 Intermediate Similarity NPD5401 Approved
0.7848 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD2799 Discontinued
0.7836 Intermediate Similarity NPD7251 Discontinued
0.7836 Intermediate Similarity NPD6559 Discontinued
0.7834 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD6651 Approved
0.7826 Intermediate Similarity NPD6599 Discontinued
0.7805 Intermediate Similarity NPD3882 Suspended
0.7792 Intermediate Similarity NPD2935 Discontinued
0.7792 Intermediate Similarity NPD5406 Approved
0.7792 Intermediate Similarity NPD5405 Approved
0.7792 Intermediate Similarity NPD5408 Approved
0.7792 Intermediate Similarity NPD1551 Phase 2
0.7792 Intermediate Similarity NPD5404 Approved
0.7791 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD7808 Phase 3
0.7785 Intermediate Similarity NPD4908 Phase 1
0.7771 Intermediate Similarity NPD2309 Approved
0.7736 Intermediate Similarity NPD2533 Approved
0.7736 Intermediate Similarity NPD2532 Approved
0.7736 Intermediate Similarity NPD2534 Approved
0.7727 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD1465 Phase 2
0.7683 Intermediate Similarity NPD8455 Phase 2
0.7682 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD5953 Discontinued
0.7644 Intermediate Similarity NPD8313 Approved
0.7644 Intermediate Similarity NPD8312 Approved
0.7595 Intermediate Similarity NPD7003 Approved
0.7584 Intermediate Similarity NPD1203 Approved
0.7566 Intermediate Similarity NPD3268 Approved
0.7564 Intermediate Similarity NPD6099 Approved
0.7564 Intermediate Similarity NPD6100 Approved
0.7558 Intermediate Similarity NPD7286 Phase 2
0.7556 Intermediate Similarity NPD4360 Phase 2
0.7556 Intermediate Similarity NPD4363 Phase 3
0.7533 Intermediate Similarity NPD2798 Approved
0.7529 Intermediate Similarity NPD3926 Phase 2
0.7528 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD4287 Approved
0.7517 Intermediate Similarity NPD3225 Approved
0.7516 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2346 Discontinued
0.7484 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD943 Approved
0.7467 Intermediate Similarity NPD2797 Approved
0.7444 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD7458 Discontinued
0.7439 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD1610 Phase 2
0.7425 Intermediate Similarity NPD4288 Approved
0.7412 Intermediate Similarity NPD1247 Approved
0.7397 Intermediate Similarity NPD1548 Phase 1
0.7396 Intermediate Similarity NPD919 Approved
0.7386 Intermediate Similarity NPD4625 Phase 3
0.7375 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4628 Phase 3
0.7368 Intermediate Similarity NPD7229 Phase 3
0.7368 Intermediate Similarity NPD3787 Discontinued
0.7338 Intermediate Similarity NPD3764 Approved
0.7322 Intermediate Similarity NPD4361 Phase 2
0.7322 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD6832 Phase 2
0.7317 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD422 Phase 1
0.7315 Intermediate Similarity NPD1201 Approved
0.7308 Intermediate Similarity NPD5124 Phase 1
0.7308 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7177 Discontinued
0.7299 Intermediate Similarity NPD3751 Discontinued
0.7278 Intermediate Similarity NPD4308 Phase 3
0.7278 Intermediate Similarity NPD7033 Discontinued
0.7267 Intermediate Similarity NPD9717 Approved
0.7237 Intermediate Similarity NPD1470 Approved
0.7237 Intermediate Similarity NPD3267 Approved
0.7237 Intermediate Similarity NPD1164 Approved
0.7237 Intermediate Similarity NPD3266 Approved
0.7225 Intermediate Similarity NPD8151 Discontinued
0.7219 Intermediate Similarity NPD2296 Approved
0.7208 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD5710 Approved
0.7168 Intermediate Similarity NPD5711 Approved
0.7166 Intermediate Similarity NPD6777 Approved
0.7166 Intermediate Similarity NPD6780 Approved
0.7166 Intermediate Similarity NPD6782 Approved
0.7166 Intermediate Similarity NPD6776 Approved
0.7166 Intermediate Similarity NPD6779 Approved
0.7166 Intermediate Similarity NPD6778 Approved
0.7166 Intermediate Similarity NPD6781 Approved
0.7152 Intermediate Similarity NPD1608 Approved
0.7143 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7584 Approved
0.7115 Intermediate Similarity NPD1296 Phase 2
0.711 Intermediate Similarity NPD7199 Phase 2
0.7105 Intermediate Similarity NPD7870 Phase 2
0.7105 Intermediate Similarity NPD7871 Phase 2
0.7099 Intermediate Similarity NPD2654 Approved
0.7091 Intermediate Similarity NPD7447 Phase 1
0.7074 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7783 Phase 2
0.7053 Intermediate Similarity NPD7696 Phase 3
0.7053 Intermediate Similarity NPD7697 Approved
0.7053 Intermediate Similarity NPD7435 Discontinued
0.7053 Intermediate Similarity NPD7698 Approved
0.7039 Intermediate Similarity NPD3972 Approved
0.703 Intermediate Similarity NPD7213 Phase 3
0.703 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7212 Phase 2
0.7029 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD4307 Phase 2
0.7025 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD1613 Approved
0.7022 Intermediate Similarity NPD1729 Discontinued
0.7006 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6798 Discontinued
0.6993 Remote Similarity NPD4749 Approved
0.6989 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6585 Discontinued
0.6981 Remote Similarity NPD447 Suspended
0.6981 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6975 Remote Similarity NPD1471 Phase 3
0.6954 Remote Similarity NPD17 Approved
0.6946 Remote Similarity NPD6273 Approved
0.6941 Remote Similarity NPD5890 Approved
0.6941 Remote Similarity NPD5889 Approved
0.694 Remote Similarity NPD8150 Discontinued
0.6928 Remote Similarity NPD1481 Phase 2
0.6923 Remote Similarity NPD2861 Phase 2
0.6911 Remote Similarity NPD6823 Phase 2
0.6909 Remote Similarity NPD3295 Clinical (unspecified phase)
0.6907 Remote Similarity NPD7701 Phase 2
0.6901 Remote Similarity NPD7577 Discontinued
0.6901 Remote Similarity NPD6844 Discontinued
0.6901 Remote Similarity NPD37 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data